OBJECTIVES: The standard of care regarding endoscopic vein harvesting (EVH) is still inhomogeneous across Europe. The current study aimed at elucidating patient-related factors favouring its application and procedure-related outcome in a tertiary care centre.
INTRODUCTION
Coronary artery bypass grafting (CABG) is the procedure of choice in a significant proportion of patients with coronary artery disease [1] . It is one of the most discussed and best-evaluated surgical procedures worldwide. Indications for bypass surgery are defined in the current guidelines and are agreed upon by both cardiologist and cardiac surgeons in most clinical centres. However, percutaneous coronary intervention (PCI) may appear less harmful due to its minimal-invasive character. Therefore, it is crucial for surgical centres to reduce procedural complications, postoperative pain and the size of scars.
The FREEDOM trial revealed a significant survival benefit of CABG compared with PCI for diabetic patients [2] . However, patients suffering from diabetes are also prone to develop wound infections. Conventional harvesting of the great saphenous vein, which is still the most applied bypass graft today, leaves a long incision prone to infection [3] . Endoscopic vein harvesting (EVH) for the great saphenous vein is increasingly applied in CABG patients [4] . The main advantage of this technique is a reduced wound area, leading to improved cosmetic results and a reduced risk of wound infection [4] [5] [6] [7] [8] . Diabetic patients are prone to suffer from impaired wound healing and may therefore be ideal candidates for EVH.
The patency of endoscopically harvested veins is still under debate. Lopes et al. [9] questioned the reliability and long-time durability in a meta-analysis of the PREVENT IV trial. However, the trial was not designed for this analysis and therefore had several limitations.
The major debate regarding the patency of endoscopically harvested vein grafts hindered its introduction as a standard of care. More recent trials focus on this issue and report no differences regarding myocardial ischaemia or death according to the harvesting method [4, 8, 10, 11] . Although this new promising data, the application of EVH is, compared with the USA, still limited in Europe [10, 12] . In addition to the open discussion on graft patency, other factors may influence the routine application in clinical practice. EVH is performed by physician assistants in the USA, but is the duty of young residents across Europe. EVH has a significant learning curve, and every young resident has to go through it. Further, young surgeons are keen to learn advanced surgical procedures and therefore do not foster EVH [13] .
A limited application of EVH for whatever reason may lead to a selection bias. In the current study, we aimed to analyse whether patient-related factors may influence the decision about the vein harvesting method. Furthermore, this analysis will provide factors influencing the outcome regarding wound healing and mortality in a single centre.
MATERIALS AND METHODS

Study population
All patients who underwent CABG at a single institute between 2008 and 2011 were included. Emergent or rescue procedures and all-arterial revascularizations were excluded. The attending surgeon chose the vein harvesting method without strict guidelines. However, the revascularization concept for every patient was discussed in the daily team meeting. We used the systems VASOVIEW 6 and VASOVIEW HEMOPRO 2 (Maquet Holding GmbH & Co. KG, Rastatt, Germany) according to the surgeon's preference.
Data management
The internal review board approved this project. Patients' characteristics, risk factors and risk scores (linear and logistic EuroSCORE I) and surgical details including the vein harvesting method were entered prospectively in the documentation system of our department. Thirty-day survival was obtained by phone follow-up, and database entries were validated. Furthermore, all postoperative hospitalizations and ambulatory visits were assessed for impaired wound healing (including infection). Mortality data were retrieved from the countrywide statistical database.
Statistical analysis
Descriptive statistical methods were applied to depict the study population regarding preoperative risk factors. A χ 2 test was performed to analyse the frequencies of binary outcomes between treatment groups. Linear variables were presented as mean and standard deviations. Further, analysis of variance was used to assess differences in outcome parameters between EVH and conventional vein harvesting. Odds ratios (ORs) were calculated for mortality and adverse outcomes according to study groups. We additionally performed multivariate logistic regressions to analyse the influence of preoperative risk factors on the attendants' decision regarding the vein harvesting technique and to analyse pre-and perioperative risk factors including the vein harvesting technique on postoperative outcome. A P-value <0.05 was considered as significant. SPSS 18 (IBM, Armonk, USA) was used for analyses.
RESULTS
A total of 262 EVH patients and 623 open vein harvested patients were included. Patient characteristics and preoperative risk factors are depicted in Table 1 . Patients receiving EVH were more likely male as well as taller and heavier, but had a similar body mass index compared with the conventional group. Diabetes was more common (44 vs 35%) and peripheral vascular disease was less common (16 vs 35%) in the EVH group. Twenty-nine percent of the procedures in the EVH group were combined with valve surgery, which was significantly less than in the open vein harvest group (36%; P < 0.05). This was due to an increased number of aortic valve replacements in the conventional vein harvesting group (29 vs 20%; P = 0.008). Other heart valve procedures were equally distributed between groups (7% mitral valve reconstruction, 2% mitral valve replacement and 1% tricuspid valve reconstruction; P = ns between treatment groups). Fifty-one percent of EVH patients were New York Heart Association (NYHA) Class III or IV, whereas 62% in the open vein harvested group were in NYHA Class III-IV (P = 0.004). The linear EuroSCORE was lower for EVH (5.7 ± 3.3 vs 6.4 ± 3.3; P = 0.01), and the logistic EuroSCORE showed a similar trend (7.8 ± 9.6 vs 9.3 ± 10.7; P = 0.084).
For EVH, the number of diseased vessels (2.7 ± 0.6 vs 2.5 ± 0.7; P < 0.001) as well as the number of bypass grafts (arterial: 1.0 ± 0.5 vs 0.9 ± 0.6; P = 0.016, venous 2.0 ± 0.8 vs 1.7 ± 0.8; P < 0.001) were significantly increased. Further, EVH patients required less periprocedural blood transfusions (1.4 ± 1.8 vs 1.8 ± 3.0; P = 0.017). This difference remained significant after correcting for combined valve procedures (P = 0.035). Other periprocedural factors did not differ significantly ( Table 2) . The observed operative mortality was 5.3% in the EVH group and 7.1% in the open vein harvested group, which was lower than the predicted mortality and not significantly different between groups. One-and 2-year survival were also similar ( Table 2) . Minor wound healing complications were more common in the open group (10.3 vs 3.8%; P = 0.001, Table 3 ). Severe complications in the leg requiring surgical revision occured in 2.4% of open vein harvested patients compared with 1.1% for EVH patients (P = ns).
A total of 16 surgeons operated in the analysed time period with a case number of analysed procedures between 14 and 130. The percentage of EVH per surgeon ranged from 13 to 67% (Fig. 1 ). There was a significant negative correlation between the choice of EVH and impaired wound healing in the leg (Pearson's correlation coefficient: −0.53; P = 0.034).
We performed a multivariant logistic regression analysis to identify the variables most likely influencing the decision for EVH. Therefore, all variables differing between the groups as well as age and body mass index were included in the analysis (Table 4) . Peripheral artery disease remained a risk factor predisposing open vein harvesting (OR 1.9; P = 0.001) and pre-existing diabetes, and a higher number of diseased coronary vessels favoured EVH (OR for open vein harvesting 0.6 for both comparisons, P = 0.003 for diabetes and P = 0.002 for the number of diseased vessels).
Furthermore, we analysed the risk factors for developing any kind of wound-healing complication in the leg. All known or potential risk factors for impaired wound healing and infection were included (Table 5) . After multivariate regression analysis, only female gender remained as a significant risk factor, with an OR of 2.4 (P = 0.001). EVH significantly reduced the risk of woundhealing complications with an OR of 0.4 (P = 0.008). An analysis of the same risk factors for severe leg complications requiring BMI: body mass index; CHF: congestive heart failure; ns: not significant.
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DISCUSSION
Surgeons at our department choose EVH in about 30% of all CABG patients with a very variable personal acceptance rate (Fig. 1 ). In comparison with the application of EVH in the USA, we apply this technique very restrictively [12] . Although the percentage of EVH application varied widely between surgeons, patientrelated factors had an impact on its application. After multivariate regression analysis, diabetes and the number of required vein grafts remained the only two factors positively influencing the decision for EVH. It is therefore arguable that pre-existing diabetes and an anticipated longer incision in the leg are perceived as significant risk factors for postoperative wound infection, and EVH is therefore favoured over open vein harvesting in these patients. Although other factors like sex and angina were also different in the univariate analyses, these factors did not differ in the multivariate approach. Peripheral artery disease seems to hinder the liberal application of EVH. Peripheral artery disease is discussed as a contraindication for EVH due to possible malperfusion induced by pressurized CO 2 insufflation. However, in our multivariate analysis of risk factors for wound-healing complications, peripheral artery disease did not play a significant role. In addition, we did not observe any EVH-related problems in patients with peripheral artery disease. Therefore, we suggest that EVH is safe in patients with peripheral artery disease, and the advantages of EVH regarding wound healing outweigh the potential risks of malperfusion and complications in the leg. However, it is crucial to set the maximum pressure for CO 2 insufflation below the central venous pressure.
EVH could significantly reduce the number of periprocedurally transfused red blood cell units. In our opinion, the reduced wound area led to a decreased blood loss during surgery that directly influenced the requirement of blood transfusions. Further, EVH dramatically reduced postoperative wound-healing complications in the leg. This is in line with several trials regarding EVH [7, 11] . In addition to the beneficial effects on wound healing, reduced postoperative pain and improved mobilization may also be present in EVH patients. However, no significant difference in the length of postoperative stay could be detected in our population.
We observed patients with haematoma formation requiring revision after EVH. Therefore, we adapted our practice and applied a closed suction drainage thereafter in every patient, which hindered further severe haematoma formation requiring revision [14] .
To analyse the impact of EVH in combination with patientrelated risk factors, we performed a multivariate analysis of known and potential risk factors for the development of impaired wound healing after CABG [15] [16] [17] . As expected, EVH was a very strong predictor of reduced wound healing complications. However, female gender turned out to be the sole remaining risk factor for impaired wound healing and severe wound complications after CABG. Although female gender was no predictive factor for the choice of the vein harvesting method, it seems to be a strong risk factor for impaired wound healing. The gender difference observed in this trial may be explained by a different fat distribution between men and women. We suggest, therefore, an increased application of EVH in female patients undergoing CABG.
CONCLUSIONS
EVH dramatically reduced postoperative wound-healing complications. Women were more likely to develop mild and severe leg wound complications. Therefore, women may benefit even more from EVH. In general, favourable outcomes of EVH should result in a more widespread use of this technology in men and women.
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